These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 22320419

  • 1. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
    Fulgêncio Gde O, Viana FA, Ribeiro RR, Yoshida MI, Faraco AG, Cunha-Júnior Ada S.
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):350-8. PubMed ID: 22320419
    [Abstract] [Full Text] [Related]

  • 2. Continuous monitoring of circadian variations in intraocular pressure by telemetry system throughout a 12-week treatment with timolol maleate in rabbits.
    Akaishi T, Ishida N, Shimazaki A, Hara H, Kuwayama Y.
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):436-44. PubMed ID: 16386085
    [Abstract] [Full Text] [Related]

  • 3. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system.
    Aggarwal D, Kaur IP.
    Int J Pharm; 2005 Feb 16; 290(1-2):155-9. PubMed ID: 15664141
    [Abstract] [Full Text] [Related]

  • 4. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
    Huang J, Peng T, Li Y, Zhan Z, Zeng Y, Huang Y, Pan X, Wu CY, Wu C.
    AAPS PharmSciTech; 2017 Nov 16; 18(8):2919-2926. PubMed ID: 28429294
    [Abstract] [Full Text] [Related]

  • 5. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
    Battistini FD, Tártara LI, Boiero C, Guzmán ML, Luciani-Giaccobbe LC, Palma SD, Allemandi DA, Manzo RH, Olivera ME.
    Eur J Pharm Sci; 2017 Jul 15; 105():188-194. PubMed ID: 28506871
    [Abstract] [Full Text] [Related]

  • 6. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery.
    Zhao R, Li J, Wang J, Yin Z, Zhu Y, Liu W.
    AAPS PharmSciTech; 2017 May 15; 18(4):997-1008. PubMed ID: 28101726
    [Abstract] [Full Text] [Related]

  • 7. Mucoadhesive chitosan films as a potential ocular delivery system for ofloxacin: preliminary in vitro studies.
    de Oliveira Fulgêncio G, Viana FA, Silva RO, Lobato FC, Ribeiro RR, Fanca JR, Byrro RM, Faraco AA, da Silva Cunha-Júnior A.
    Vet Ophthalmol; 2014 Mar 15; 17(2):150-5. PubMed ID: 24428388
    [Abstract] [Full Text] [Related]

  • 8. Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects.
    Huang SF, Chen JL, Yeh MK, Chiang CH.
    J Ocul Pharmacol Ther; 2005 Dec 15; 21(6):445-53. PubMed ID: 16386086
    [Abstract] [Full Text] [Related]

  • 9. The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits.
    Shafaa MW, Sabra NM, Fouad RA.
    Biopharm Drug Dispos; 2011 Dec 15; 32(9):507-17. PubMed ID: 22028305
    [Abstract] [Full Text] [Related]

  • 10. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma.
    Hegde RR, Bhattacharya SS, Verma A, Ghosh A.
    Curr Eye Res; 2014 Feb 15; 39(2):155-63. PubMed ID: 24073659
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In Situ Gelling Electrospun Ocular Films Sustain the Intraocular Pressure-Lowering Effect of Timolol Maleate: In Vitro, Ex Vivo, and Pharmacodynamic Assessment.
    Andreadis II, Karavasili C, Thomas A, Komnenou A, Tzimtzimis M, Tzetzis D, Andreadis D, Bouropoulos N, Fatouros DG.
    Mol Pharm; 2022 Jan 03; 19(1):274-286. PubMed ID: 34877863
    [Abstract] [Full Text] [Related]

  • 15. Crosslinked soy protein films and their application as ophthalmic drug delivery system.
    González A, Tártara LI, Palma SD, Alvarez Igarzabal CI.
    Mater Sci Eng C Mater Biol Appl; 2015 Jun 03; 51():73-9. PubMed ID: 25842110
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
    Maulvi FA, Lakdawala DH, Shaikh AA, Desai AR, Choksi HH, Vaidya RJ, Ranch KM, Koli AR, Vyas BA, Shah DO.
    J Control Release; 2016 Mar 28; 226():47-56. PubMed ID: 26860285
    [Abstract] [Full Text] [Related]

  • 17. In vitro release and characterization of chitosan films as dexamethasone carrier.
    Rodrigues LB, Leite HF, Yoshida MI, Saliba JB, Cunha AS, Faraco AA.
    Int J Pharm; 2009 Feb 23; 368(1-2):1-6. PubMed ID: 18955123
    [Abstract] [Full Text] [Related]

  • 18. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
    Aburahma MH, Mahmoud AA.
    AAPS PharmSciTech; 2011 Dec 23; 12(4):1335-47. PubMed ID: 21979886
    [Abstract] [Full Text] [Related]

  • 19. Development of O/W nanoemulsions for ophthalmic administration of timolol.
    Gallarate M, Chirio D, Bussano R, Peira E, Battaglia L, Baratta F, Trotta M.
    Int J Pharm; 2013 Jan 20; 440(2):126-34. PubMed ID: 23078859
    [Abstract] [Full Text] [Related]

  • 20. Chitosan-Gelatin Hydrogel Crosslinked With Oxidized Sucrose for the Ocular Delivery of Timolol Maleate.
    El-Feky GS, Zayed GM, Elshaier YAMM, Alsharif FM.
    J Pharm Sci; 2018 Dec 20; 107(12):3098-3104. PubMed ID: 30165067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.